CLARNET
is a comprehensive research infrastructure that integrates advanced preclinical large-animal models, clinical and interventional expertise, sophisticated imaging technologies, and a robust data ecosystem. Its primary focus lies in cardiology and neurology, while remaining open to broader biomedical fields. CLARNET’s translational environment spans the full development pipeline of modern medicine—from cellular and animal experimental models, through diagnostics and interventions, to therapeutic strategies. This includes advanced data management solutions and AI-augmented signal analysis.
CLARNET
By combining large-animal research, state-of-the-art imaging, interventional technologies, and high-performance data analytics, CLARNET represents an unparalleled European platform for cardio-neuro experimental research, technological innovation, and preclinical validation.
CLARNET is working as ”single-sited” unique research facility, oriented on large animal experimentation. Functionally it is consortium of Veterinary Research institute (VRI) and International Clinical Research Center St Ann´s University Hospital (FNUSA-ICRC), providing human clinical relevance, experiment conduction and evaluation under an Agreement from 2020, see attached to this questionnaire Moreover data curation and education are taking place as well. The design of the partnership took place since 2018, resulting of first common experiments in 2020. During following five years numerous teams collaborated on investigator initiated research as well as contracted research projects. The project is thus in “operation” stage for cardiology, but also regularly are conducted experiment of reconstructive surgery, orthopaedics, with possible extension as pilot trials on neurocardiac stimulation, oncological research and biomedical engineering. The operation is based at VRI Brno, Czech Republic.